CN101519446A - 一种重组人胰岛素及其类似物的制备方法 - Google Patents
一种重组人胰岛素及其类似物的制备方法 Download PDFInfo
- Publication number
- CN101519446A CN101519446A CN200910030043A CN200910030043A CN101519446A CN 101519446 A CN101519446 A CN 101519446A CN 200910030043 A CN200910030043 A CN 200910030043A CN 200910030043 A CN200910030043 A CN 200910030043A CN 101519446 A CN101519446 A CN 101519446A
- Authority
- CN
- China
- Prior art keywords
- insulin
- proinsulin
- sequence
- clause
- analogue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200910030043A CN101519446A (zh) | 2009-03-31 | 2009-03-31 | 一种重组人胰岛素及其类似物的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200910030043A CN101519446A (zh) | 2009-03-31 | 2009-03-31 | 一种重组人胰岛素及其类似物的制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN101519446A true CN101519446A (zh) | 2009-09-02 |
Family
ID=41080268
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200910030043A Pending CN101519446A (zh) | 2009-03-31 | 2009-03-31 | 一种重组人胰岛素及其类似物的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101519446A (zh) |
Cited By (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102558356A (zh) * | 2010-12-31 | 2012-07-11 | 上海科新生物技术股份有限公司 | 一种人胰岛素原融合蛋白及人胰岛素的制备方法 |
WO2012098462A1 (en) | 2011-01-20 | 2012-07-26 | Zealand Pharma A/S | Combination of acylated glucagon analogues with insulin analogues |
US8642540B2 (en) | 2008-12-15 | 2014-02-04 | Zealand Pharma A/S | Glucagon analogues |
US8642541B2 (en) | 2008-12-15 | 2014-02-04 | Zealand Pharma A/S | Glucagon analogues |
US8680049B2 (en) | 2008-12-15 | 2014-03-25 | Zealand Pharma A/S | Glucagon analogues |
US8685919B2 (en) | 2008-12-15 | 2014-04-01 | Zealand Pharma A/S | Glucagon analogues |
US9156901B2 (en) | 2009-07-13 | 2015-10-13 | Ditte Riber | Acylated glucagon analogues |
US9169310B2 (en) | 2010-06-24 | 2015-10-27 | Zealand Pharma A/S | Glucagon analogues |
US9180169B2 (en) | 2012-09-17 | 2015-11-10 | Zealand Pharma A/S | Glucagon analogues |
US9403894B2 (en) | 2010-06-23 | 2016-08-02 | Zealand Pharma A/S | Glucagon analogues |
US9896495B2 (en) | 2013-10-17 | 2018-02-20 | Zealand Pharma A/S | Acylated glucagon analogues |
US9988429B2 (en) | 2013-10-17 | 2018-06-05 | Zealand Pharma A/S | Glucagon analogues |
US10093713B2 (en) | 2013-11-06 | 2018-10-09 | Zealand Pharma A/S | GIP-GLP-1 dual agonist compounds and methods |
US10100097B2 (en) | 2012-05-03 | 2018-10-16 | Zealand Pharma A/S | GIP-GLP-1 dual agonist compounds and methods |
US10131702B2 (en) | 2013-11-06 | 2018-11-20 | Zealand Pharma A/S | Glucagon-GLP-1-GIP triple agonist compounds |
US10253078B2 (en) | 2014-10-29 | 2019-04-09 | Zealand Pharma A/S | GIP agonist compounds and methods |
US10336802B2 (en) | 2015-04-16 | 2019-07-02 | Zealand Pharma A/S | Acylated glucagon analogue |
US10442847B2 (en) | 2012-07-23 | 2019-10-15 | Zealand Pharma A/S | Glucagon analogues |
WO2020051812A1 (zh) * | 2018-09-12 | 2020-03-19 | 美药星(南京)制药有限公司 | 一种新型门冬胰岛素原的结构和制备门冬胰岛素的方法 |
-
2009
- 2009-03-31 CN CN200910030043A patent/CN101519446A/zh active Pending
Cited By (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8642540B2 (en) | 2008-12-15 | 2014-02-04 | Zealand Pharma A/S | Glucagon analogues |
US8642541B2 (en) | 2008-12-15 | 2014-02-04 | Zealand Pharma A/S | Glucagon analogues |
US8680049B2 (en) | 2008-12-15 | 2014-03-25 | Zealand Pharma A/S | Glucagon analogues |
US8685919B2 (en) | 2008-12-15 | 2014-04-01 | Zealand Pharma A/S | Glucagon analogues |
US10004786B2 (en) | 2009-07-13 | 2018-06-26 | Zealand Pharma A/S | Acylated glucagon analogues |
US9156901B2 (en) | 2009-07-13 | 2015-10-13 | Ditte Riber | Acylated glucagon analogues |
US9403894B2 (en) | 2010-06-23 | 2016-08-02 | Zealand Pharma A/S | Glucagon analogues |
US9169310B2 (en) | 2010-06-24 | 2015-10-27 | Zealand Pharma A/S | Glucagon analogues |
CN102558356A (zh) * | 2010-12-31 | 2012-07-11 | 上海科新生物技术股份有限公司 | 一种人胰岛素原融合蛋白及人胰岛素的制备方法 |
WO2012098462A1 (en) | 2011-01-20 | 2012-07-26 | Zealand Pharma A/S | Combination of acylated glucagon analogues with insulin analogues |
US10100097B2 (en) | 2012-05-03 | 2018-10-16 | Zealand Pharma A/S | GIP-GLP-1 dual agonist compounds and methods |
US11795204B2 (en) | 2012-07-23 | 2023-10-24 | Zealand Pharma A/S | Glucagon analogues |
US10442847B2 (en) | 2012-07-23 | 2019-10-15 | Zealand Pharma A/S | Glucagon analogues |
US9975939B2 (en) | 2012-09-17 | 2018-05-22 | Zealand Pharma A/S | Glucagon analogues |
US9180169B2 (en) | 2012-09-17 | 2015-11-10 | Zealand Pharma A/S | Glucagon analogues |
US10253081B2 (en) | 2012-09-17 | 2019-04-09 | Zealand Pharma A/S | Glucagon analogues |
US9988429B2 (en) | 2013-10-17 | 2018-06-05 | Zealand Pharma A/S | Glucagon analogues |
US9896495B2 (en) | 2013-10-17 | 2018-02-20 | Zealand Pharma A/S | Acylated glucagon analogues |
US11884713B2 (en) | 2013-10-17 | 2024-01-30 | Zealand Pharma A/S | Acylated glucagon analogues |
US11034747B2 (en) | 2013-10-17 | 2021-06-15 | Zealand Pharma A/S | Glucagon analogues and methods of use |
US11091528B2 (en) | 2013-10-17 | 2021-08-17 | Zealand Pharma A/S | Acylated glucagon analogues |
US10457714B2 (en) | 2013-10-17 | 2019-10-29 | Zealand Pharma A/S | Acylated glucagon analogues |
US10131702B2 (en) | 2013-11-06 | 2018-11-20 | Zealand Pharma A/S | Glucagon-GLP-1-GIP triple agonist compounds |
US11008375B2 (en) | 2013-11-06 | 2021-05-18 | Zealand Pharma A/S | GIP-GLP-1 dual agonist compounds and methods |
US11111285B2 (en) | 2013-11-06 | 2021-09-07 | Zealand Pharma A/S | Glucagon-GLP-1-GIP triple agonist compounds |
US10093713B2 (en) | 2013-11-06 | 2018-10-09 | Zealand Pharma A/S | GIP-GLP-1 dual agonist compounds and methods |
US11001619B2 (en) | 2014-10-29 | 2021-05-11 | Zealand Pharma A/S | GIP agonist compounds and methods |
US10253078B2 (en) | 2014-10-29 | 2019-04-09 | Zealand Pharma A/S | GIP agonist compounds and methods |
US11814417B2 (en) | 2014-10-29 | 2023-11-14 | Zealand Pharma A/S | GIP agonist compounds and methods |
US10336802B2 (en) | 2015-04-16 | 2019-07-02 | Zealand Pharma A/S | Acylated glucagon analogue |
US11274136B2 (en) | 2015-04-16 | 2022-03-15 | Zealand Pharma A/S | Acylated glucagon analogue |
CN112584853A (zh) * | 2018-09-12 | 2021-03-30 | 美药星(南京)制药有限公司 | 一种新型门冬胰岛素原的结构和制备门冬胰岛素的方法 |
WO2020051812A1 (zh) * | 2018-09-12 | 2020-03-19 | 美药星(南京)制药有限公司 | 一种新型门冬胰岛素原的结构和制备门冬胰岛素的方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101519446A (zh) | 一种重组人胰岛素及其类似物的制备方法 | |
CN100579986C (zh) | 一种生产促胰岛素分泌肽glp-1(7-36)及glp-1类似物的方法 | |
CN104619726A (zh) | 由超折叠绿色荧光蛋白构成的融合蛋白及其用途 | |
CN101240033B (zh) | 一种促胰岛素分泌肽与人血清白蛋白的融合蛋白及其制备方法 | |
CN107245494A (zh) | Aβ42在大肠杆菌中的高效可溶性表达及纯化方法 | |
CN105198972B (zh) | 一种高纯度重组人脑利钠肽的制备方法 | |
CN107881187A (zh) | 将大肠杆菌表达的融合蛋白转化为利拉鲁肽的制备方法及应用 | |
CN104402975B (zh) | 抗衰老短肽及其制备方法 | |
CN105274134A (zh) | 拟穴青蟹抗菌肽scy2的制备方法与应用 | |
CN110724187A (zh) | 一种高效表达利拉鲁肽前体的重组工程菌及其应用 | |
CN102618552B (zh) | 一种重组艾塞那肽的生产工艺 | |
WO2023125178A1 (zh) | 一种融合蛋白及其制备司美格鲁肽中间体多肽的方法 | |
CN112522294B (zh) | 一种glp-1类似物的半重组制备方法 | |
CN114933658B (zh) | 一种短肽元件及其应用方法 | |
EP3807306A2 (en) | Leader sequence for higher expression of recombinant proteins | |
CN102190720A (zh) | 一种人胰高血糖素样肽-2(1-35肽)类似物制备方法 | |
CN109776653B (zh) | 一种人血清白蛋白黏附肽及其应用 | |
CN113121672B (zh) | 猫干扰素γ的可溶性原核表达和纯化方法及应用 | |
CN103789321B (zh) | 一种重组人胸腺肽α1的制备方法 | |
CN109971776A (zh) | 基于光切割基序的蛋白纯化方法 | |
CN105218659B (zh) | 人骨形成蛋白2成熟肽及其表达 | |
CN102827286A (zh) | 一种促胰岛素分泌肽与突变的人血清白蛋白的融合蛋白及其制备方法 | |
CN1059703C (zh) | 人胰岛素前体基因在大肠杆菌中的直接表达及后加工方法 | |
CN108840934B (zh) | 一种重组羊长效干扰素τ及制备此长效干扰素的融合蛋白及其制备方法 | |
CN102168057B (zh) | 表达多活性肽的工程菌及制备混合多肽的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C57 | Notification of unclear or unknown address | ||
DD01 | Delivery of document by public notice |
Addressee: Fan Hao Document name: Notification of Passing Preliminary Examination of the Application for Invention |
|
C06 | Publication | ||
C57 | Notification of unclear or unknown address | ||
DD01 | Delivery of document by public notice |
Addressee: Fan Hao Document name: Notification that Application Deemed not to be Proposed |
|
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C57 | Notification of unclear or unknown address | ||
DD01 | Delivery of document by public notice |
Addressee: Fan Hao Document name: Notice of application for publication of patent for invention and entry into the substantive examination procedure Addressee: Fan Hao Document name: Notification that Application Deemed not to be Proposed |
|
AD01 | Patent right deemed abandoned |
Effective date of abandoning: 20090902 |
|
C20 | Patent right or utility model deemed to be abandoned or is abandoned |